A Novel, Blocking, Fc-Silent Anti-CD40 Monoclonal Antibody Prolongs Nonhuman Primate Renal Allograft Survival in the Absence of B Cell Depletion

This publication has 35 references indexed in Scilit:

• Antibody-mediated rejection, T cell–mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies
  Kidney International, 2014
• Nondepleting Anti-CD40-Based Therapy Prolongs Allograft Survival in Nonhuman Primates
  American Journal of Transplantation, 2011
• Molecular Correlates of Renal Function in Kidney Transplant Biopsies
  Journal of the American Society of Nephrology, 2009
• Analysis of independent microarray datasets of renal biopsies identifies a robust transcript signature of acute allograft rejection
  Transplant International, 2009
• The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells
  Blood, 2008
• A Novel Fully Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys
  Transplantation, 2007
• Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model1
  Transplantation, 2004
• Anti-CD40 therapy extends renal allograft survival in rhesus macaques1
  Transplantation, 2002
• The Banff 97 working classification of renal allograft pathology
  Kidney International, 1999
• Molecular and biological characterization of a murine ligand for CD40
  Nature, 1992